Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-02-26
1988-03-29
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 31425
Patent
active
047344229
ABSTRACT:
Aroylthiazolones enhance myocardial contractile force and are useful as cardiotonics in the treatment of heart failure.
REFERENCES:
patent: 4418070 (1983-11-01), Okonogi et al.
patent: 4623651 (1986-11-01), Grisar
patent: 4649146 (1987-03-01), Takaya et al.
patent: 4670450 (1987-06-01), Schnettler et al.
Chem. Abst. 84: 135629(s)(1976)-Manghisi et al.
U.S. Ser. No. 787,276, filed 10-15-85.
U.S. Ser. No. 787,226, filed 10-15-85.
U.S. Ser. No. 797,579, filed 11-13-85.
Dage Richard C.
Grisar J. Martin
Schnettler Richard A.
Merrell Dow Pharmaceuticals Inc.
Nesbitt Stephen L.
Robinson Douglas W.
LandOfFree
Cardiotonic aroylthiazolones and the use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cardiotonic aroylthiazolones and the use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cardiotonic aroylthiazolones and the use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1089246